Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQblJPZFZRSFZjTW01Y2o2dUY3cVJ3dTRPS2dnUDdXcnhCWGZpdW5neFZSbFhGR3I0V0ZtUnQtRHVwZlNrdWZCWktPV1dob0pTeTZmLTEwQUR3TExiQTRzb3lZUkUxbklkR3loNXpDYmpNMV8xWW82ZGo4eXJJSTZna3ZSSVZtUDhNWC01VDVCVFU1TDdjWDN6SVAtdWlZZC1iYk4wMGV6WFBNZEVob0Zzek5XaS0?oc=5" target="_blank">Exploring Early Breast Cancer: Advancing Research Across the Treatment Journey</a>&nbsp;&nbsp;<font color="#6f6f6f">Daiichi Sankyo US</font>
October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"
Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows
LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNOXJOalNhZlc0WUdTY0tJMFhhQVNsM05KeHVoWXh6eWhoSHNDbGtPb3h6R1RxVWJhVWZqUzhsNkxFS1pWTUNjcnVtdll4QjltOUgxOFZjbHpJeEZlZE9HQlJaNVdEdHRZTVZOcC1HVndfZVVxOURSbXJTcXk1eHZiekpRUFJ6S1haN1Vncw?oc=5" target="_blank">Breast Cancer Recurrence: Risk Factors & Prevention</a>&nbsp;&nbsp;<font color="#6f6f6f">HealthCentral</font>
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOX0hvRWNiY2NtWHFmX0hhNmU4eHd2RlFJamlONE5EcTEyOThuOTBzX0N6UGE0WEhDaGtGSFJGQy1zZFdjdzkxRmF6SHZhV2hPX0pySHFiN2lHUTM4aUVzdzlaVlpJdE4yMTlQSjQ4STkzWkVaRWpVQ2dXazVmWXZBNnZxN3Vzc0R1WXc?oc=5" target="_blank">A Conversation Women Wish They’d Had: Understanding the Risk of Breast Cancer Coming Back</a>&nbsp;&nbsp;<font color="#6f6f6f">Novartis</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQcTI2UkhHUlFJOXQ3ZEplaFJLdnVUdWNxSFF3cEZrdV9HRDdqMjFFZUlnTFlzTGg4TjBpNkU5clh3VHpqbVFwZUo0VklpT3NhTS1JUWpmRC1IUXhrRWRLQURUVVNOd0NOQnVDenA0UUpiLVFINE5RVVJjcHJkYkgzQzl1RFc5NGE3cHZrWC1GcTdIdXhzeWFEMVlZNDZlQ1dzbXVVU29Hb0N3UDlaMGdCWW9DekVpQzdDWlZKbzVEaTVsUl9CS3Bn?oc=5" target="_blank">AI could offer more precise breast cancer recurrence risk, study finds</a>&nbsp;&nbsp;<font color="#6f6f6f">MedicalNewsToday</font>
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNYl9PcEh4c0N1cVQ1U2tndVlvb2p5TllnQnpSWU1nX2RzLVprX0pTalRMYUU0d0RnWFpiQktzajdyWU9aRW1nUDhsRk1hbW9scVdlZnBDUC1BMXJ5WnhGT0d3MkQtYXhBNGpDSW0xeTlJU01BcGkwRVljR0xFVnFqRUNyNjBtRUFlOTVSU3d6RjM0cE4yTVczSWR5YXZOWWNvRmJSVjF0NjB3TVQ4QTVqOWhLQ1BiRmxScy1RaGhwcjg?oc=5" target="_blank">Multi-Omic Test Predicts Radiation Therapy Benefit in Early-Stage Breast Cancer, Study Finds</a>&nbsp;&nbsp;<font color="#6f6f6f">Clinical Lab Products</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxONzVIWjBmOUhoal94ZzJXY1Roam5wZVpId2FLdWxuU2UzMDY1RXVNMEMtenZUZEtrYWVBRXdJRTZrM0lNMmpoRnhSc1N2VkJSZE5zY3dFVEZjQXl5WnFvNkNzQmZaTHJJOGJ3OGUwczgwN1JTRW5JZ0RBNTRGSEFkQWR0bFpqQ1ZtN2tFeDdaR0pZemMtaTUxUGNGc3lWZw?oc=5" target="_blank">OHSU and Legacy spotlight new tools in breast cancer care</a>&nbsp;&nbsp;<font color="#6f6f6f">The Business Journals</font>
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPYnhxUVVZTExFdzF1LXhJOHVHcWN4TTZ1S2E1MFFGR1lnOWhkNWVzRUw4Q0NNVXVuNkFGR3VxYm5NUXM1V3pnZHQ1cnlHbnZYeS1sSWtFMHdnblc4MTN3d3FiaU9ITEpObnMwV2x4SUFKTmpSVi1Xc21OeC1uVHlxNC1BN1hOUjZaSnRNOHpfY3hkYllSRWJaOFY3VzVqa3pQdThQaEpnZG5LSGtuV0NtSXVIRTVCUS1aTkVDOFdBQVlHYzFQMlFfUU9kbWNmaUt6TGc?oc=5" target="_blank">Guideline Update Recommends Tailoring Breast Cancer Surveillance Based on Recurrence Risk</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE85VDVmc0VJNWttUWFzUndxZl9ON0h0SVl4dlYyazN1ck4wT3lORUxvRHA0SlNkanVxMHhmMlBHcHdxQ3lRcXJ0dFpxekF4YWstbV9TRlFqNDRDWEw1b3Rz?oc=5" target="_blank">Multidimensional MRI radiomics-based model predicts recurrence risk in triple-negative breast cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNeU9zX2lWOXUxRlc2VTJJeVFCYmk3amVBZE5oZl8yUUNpOHNQdDhYYnFKeFBHQ0Q2eXk2UDJaN2NtSl83Ql81TDdyZHlnbUFyeGJtdDFFazVLc19SMWdBZTJHMUVYWkNjMUFMVGthYkJSU3BBQ0E2dTl4X0gyNnVrM0pQSQ?oc=5" target="_blank">A new AI-powered test offers more accurate prediction of breast cancer recurrence risk</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Xpress</font>
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOdjZuN0ljRTNpUEFmMmJxbHhqcG5XbktTUUo0RUNFY0pOOWRiUHBiWU1CWHJBWWROMEVzNENvb2pScTJHNjZFWG1PNllCTDk3UEdhcTVfWURqTkR6dFpMY2lwUTNHejE2eTRIYUhrM1JDTElDU1duWFp3b3ozWkFHdWZzRk9yM19MQXZmTV9GY05PdWxrQUc0TktnRTdIdU1tQ0NXQUtjMDlIblZCZjJYY1k1UQ?oc=5" target="_blank">Lifestyle Interventions Are Associated With Reduced Recurrence of HR-Positive Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">ASCO Daily News</font>
<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WNGtkLV92LTdaZHUyemF6TFNpN2diUHZLUUpvanB2R1RyLWdBX1A2RVY1Y2Z6c3N5NW5kcGdZdmdKSThhcnFnanBaQ2xXdHRYb3hCOXIwNDR3SnN6M1FKUGlmSm1qdw?oc=5" target="_blank">5 New Findings About GLP-1s and Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Breast Cancer.org</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPbWlMZnM3LV9YeWktLVFKOXZrOGdVUjRaU3huMldSQjhzWm14R2wxb2RDdjhVZzNvazRXSkt3YkZPbjVxS3hCLTlEdmpMZTlqQVJXemlWYjVKbnBvS3QycFpYOE8zRVFaTXJpR0F5ZUMxcm1iNXV1aW9iSmd5NFdqb2FUMXVhNDZDMHhXSnV2Y3MxRmQwaWpIMUR2REl2b1hTbXh3Mg?oc=5" target="_blank">GLP-1s in Breast Cancer: Overall Survival, Recurrence Risk, and Safety</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPa2VrODNiZklGQ29fd25pS0R2UW1YWThiUlI0SDVYZG9ISnVBaFJIcHBsYks1LUtZNzloX1gtdGVYTXlsTFAwWEMyWXFEajFaVjBwZzdUNnV4SHVQd3NkY0JUNjN1VTk0MmVkTHVCUXRGZHhCNEFYcUdXRjdnZXA0UWRWSEdNZUhqeXc?oc=5" target="_blank">What To Know About the Prognosis for Triple-Negative Breast Cancer—and Your Risk of It Returning</a>&nbsp;&nbsp;<font color="#6f6f6f">www.health.com</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQemYtMUdyWjRzMWJXbEJHa19IeDZFcWVncjFjYXJZa2g3c1YyOFhwVnRCTU96eWNFSkp3Q1dWQkpsdU5YNDh5YjlsMGVucHRYc1dhaXpCbXNEMG9DTGVDczFzbE1tdE15OG1mZGQtWVluNWtkb1JDT3hrc2pIQzExQTlKWTQtV3ZraEpGTnRJY1Z2UFh4MHZoV3N0b0VlZVduaEtRTk5B?oc=5" target="_blank">New Test Predicts Breast Cancer Recurrence and Radiation Therapy Benefit</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNN2dpMjFMZW1EaWtwbGk3VTc5dzVjYmZhNU1lNFZhNDZmLW1DUXNsYWRqWDBQbmI3Y3pYeXNncmgxSFB4YjVTa0pmTktwaVhUb1MwUWN3THZwWGhXSlhaMmtxaThfekRIT1FzdUQ5VFhEWHpmd0h5aEgtaU5kMTU4cTA3WEZ0UFU4TUVsTlNR?oc=5" target="_blank">Breast cancer recurrence risk prediction based on MIL</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOZlFDdy1fZXpmQmtwc2swOWh2Z3VDemw1cmF0VV9scElMUkpnaUtuUmI2bzZLUUhrR2ZXeFdMaDh3bTFEN09NaWo1MWNBckNhZHVJMVJmRGQ3VUpBNUZIX3dBYmpDaW9FOHFrYXlJcmNSdENTU1ZYelVDclpWSkIta0V3Z1VwQ2x2cmUzT1hUUnVicExKNThtUVI2aTZEZERvUzZwZkVIbFBtSGQ1eDE5WUVmOGFzbGJBSHc?oc=5" target="_blank">New ’tissue-free’ blood test could detect breast cancer recurrence months before scans</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology Central</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNUmhuejJQLU5qS1RJc2tYVk5WMGNHU2hMbTdTZUliSWRjWW9CcHJSWmZTMkpwOTRMa25YeW1YN2xXRzdBY3ZENUNka1pxdUFMRHZOZnBXeTVhMHNENzRqSmRseTFGQ1M1bGIyNzh3cmFBbzE4dENaZ0RBVnI5TUhXTndoS3dWeU5NNC1SeGZnN1liMjZoN1N6Uk9wVy1wSFMtQ1ZJeWJMTEJJVVk2MG5n?oc=5" target="_blank">Are Narrower Negative Margins Linked to Higher Risk of DCIS Recurrence?</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBUX3NlbEZMRnZCX2JlaUZyc3RfbWxpU094STFseUZGRTlmYm54RFNDSmVNWUNMeUw1UFh0VnkwVGlKRTRibl9kcVg1QkwzZTczclNRWnNtbGMtb0J5NGQ4?oc=5" target="_blank">Towards interpretable prediction of recurrence risk in breast cancer using pathology foundation models</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBoT1hIZlNVREFKUi1fcjQ4ZGdrZlh5b2RPRjhJRTE3bWV3dGJ2NXhVTm9UTlVBRzgxb0ZMenRMU3NoOER4M3l6VVcxY3FITmY2dWUtTUE3eXNtWkQ4SFU0M0RERDlsdkRmVzB0WQ?oc=5" target="_blank">Triple-Negative Breast Cancer Prognosis, Survival, and Recurrence</a>&nbsp;&nbsp;<font color="#6f6f6f">Breast Cancer.org</font>
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxPeXV1T0RzRmZMUUN0UHhhRVJCeVd6dVdHczVpa1ZqRUEtVU50S014U0NvTzljY3hTVUdsc0R3M05IOXBMSlJDaXZESV9KN2MtMGk2ZUoxWHdORkY1eUNrRDJHT3dDVnlZRkthbWhrTVZpZjFIcmd6c0NjZ3RHVGJsS1l2dXZ1dFBCMTdZUFUxQXN0a1BobjdFYzQ3cUhvYUpJYjJSUEt6WHFkZjVBUkcydnptXzBFbG5qajlzbWxUMzVHY2ltTnFwQ0t5aFRQWXRRVS1MNmEwZlpyMXI3Tl96NWNUMlhsbHVGbktia0E2N1RoN3YtcHVGTDByVGo?oc=5" target="_blank">Case 1: Understanding Risk of Recurrence in ER-Positive Early Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPMFJmYUR6bmRUZExvOXA4U0wydl9Lbk1GSGJ6S0l6aXBINDU4YlYxcXhaWjZYR1M1V1JMOHhXNVBhMklfSEtqdHNJZG4wcEdFQ1IxbU9wUGg4SkpkcnZlLTlrNFBNUFFLMW9hYmZCM29QOWVDcklWblp0WF9jMzdFQmJqNWpxdDBIWDhpSE9SYXhNbUZocXJTb19UR0tyOVp0Y3JrcGJUYTluVFlaUVJZTDJrSHowQQ?oc=5" target="_blank">AI Models Advance Individualized Breast Cancer Recurrence Risk Assessments</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPSTk4RVp1TzZPMnl0Mlk4RmVNRkw3anpabTRmM0FFT2o1TDllQllUazdEYl9IR1FJdzBKVkIzN1p3bUJtZHUwVm1MZWNEbnpSdUI5dmdQSy1Ca0tHMWQwaGpLcUF1NHRhVGJNTzRaN0tzMU9obnUyWGlJa0otbzg1RnV1SmpuS0VHXzB4T21pY2VkdGlkZzg5eDd6aG1PdXFHa0FkOGVyVzl2TnU4ZmhrVEp0elZoV3p2UzJVQ0NXMVRZWkc4U1A2NTAzQWJBd1Z2?oc=5" target="_blank">Managing Unseen Risks: Understanding Recurrence in Early Breast Cancer With No or Limited Nodal Involvement</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIcm0tWkRPQmJ3SWV6Y21oVUlWQi10UjhDM2d6UVdKa0thU1lnT3VNTXBhM2pYZHFFVjhvQXpBLWJkNzE3Q0c4cjJSellKWV9aNkVWQWRvUHIyTzNNdzlZ?oc=5" target="_blank">A distributed fusion framework for breast cancer recurrence prediction using MapReduce</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxPMHFCYkFpWW4waXJHcTc0T2tGYVNGTkY0eGRKYTgxRmR6WS13YmF5c29SNGxsc0VSeWRnMGtTQ2dqZXQ1bkVHTUhXQVBjVlc4ZzM3Z3QzREdpLWFaQlY2MlFSTllKMHpNTE1OQzNvSll5M2EzUm9kMlhHR2tuNndxRE5Ld0hIVU9KTjhDWGVTQU1qTlNHbTF6YnJhTXBJYmNwSUEwOTF0VGZkZ0FMTW9YaF80Y2lRVmI2RGQ1eFFMNW1ZV3NqVUNfRnhwWmlzRmJKUWw0clBUdWhVcnFvU1VsVUhrc2hLX0dfY0dXZUZJdFlGOU0yMmx5NktSYVlYODE1cmV6bjVB?oc=5" target="_blank">117 Risk of Recurrence (ROR) Among Patients With HR+/HER2− Early Breast Cancer (EBC) Involving 1-3 Axillary Lymph Nodes (N1): A Real-World Evaluation</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPdkZja0I2cGROeUdTeXhlQnh2bDNjYTlHWmtRLVZjdGd4MWpqdzJxdEhya1h0c3dHcFoxRmctNURqcUd0azFoT0Z1b1Q2ZVNCZzFDdV9JWFZiZkd6TGJEdjF5cG5BMGU4SS1Ea1dya3NoNU1ETUlkYXFrQ2pkemVxcFoyRElnYWVsU2hsN2Z3RVdqUENjM1lheTRSVjNJRkE4a0ZyUGp4Ny0tbU4tenc?oc=5" target="_blank">Narrow Margins After Lumpectomy Safe for Most DCIS Patients</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oRGplLXFOODhnUUtTTjdqSTlCUmVRUms5R0dSZlo1NkZ1cFNoMmk0QWxzc2c5NzE4QXNvbmlpU3hhc2JMWE8yWGNMTHBmdmRzaV8xOVJfdXpxVnVPYnRB?oc=5" target="_blank">A unified multi modal transformer framework for breast cancer recurrence prediction and survival analysis</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFB5VnllQTBxSVdKbGxYekZIMGdNdnFPLTQ5eUhmZ0VnS09MOWZTZlQ1NFp6eEFjeFNKOHNQcTFNSGNWTGNIYl84dS02b091eXBpZ0lNNmFRMGRVMTloekJsdTRoX0NiNW1q?oc=5" target="_blank">Breast Cancer Research Highlights from ASCO 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">Breast Cancer.org</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQMmR3QUFaZ0xNdlRTS3RUeFpGTG80WTY5Zng1SHloek1kaWlQWE9Qd082TnBjZDdrQ0VRX1Q4Mk92R3BIQndMLTIxeGpzVTZIeUNqckdEZm5jTmtXV25maW53b1YyUGpadlc1eDNPUTdLQzZHcFBTNE1HbDFMY3hxNDFDWEl1Qk1ITmRF?oc=5" target="_blank">Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOMnllYl9KR1N0TnJlVXJFRDhsZmRkazZDMko2Mkg5cG1IQ1BiRFBPMzRyR20zSUNsT0NHQko0UzY3YTRLeVc4Z3FIMExpUXVlNXhNUmhJelRWaWRSeHRIc251clJRcUpMSnowaWpKc3B6eWxETTFLX3M4YXVLVlRjMkpkU3U5Y2ZVREpMOFpjVHh0TVNzN1dHVUpHM2tJZ1BXMVpZaWZ1dFk3RXFQ?oc=5" target="_blank">AI Model Predicts Late Distant Recurrence Risk in HR-Positive Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQWVJBX2d4SXZqcnZCQ3VBaThhMUl6SHpwYThTYjlZNmlYSi1CM3RFX3RrX2hiWHdiRmZWblBMaWx3Z1g4cUdyMWJSZVBBUm1EMm1JeDlIN3JrOGNITTQyZWdnZEhDRkE5MzE1bFBWVExxZ2N1eTVKaGh0RHY1cHNmbG8xdVZyUlhRWGV1dGgyYTgtSWctRUpqcmR3OXZoTXpfek1PSzdB?oc=5" target="_blank">New Data Show Immunotherapy Reduces Breast Cancer Recurrence by Over 80%</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>